8th Clinical Trials Inspection Readiness Summit

When: August 14, 2019 - August 15, 2019
Where: Sonesta Philadelphia Downtown Rittenhouse Square, 1800 Market St, Philadelphia, PA 19103

As clinical trials are conducted, inspections ensure the quality and integrity of care, data and drug performance. As sponsors for clinical trials, pharmaceutical companies are required to ensure GCP guidelines are upheld by implementing inspection readiness. These inspections are conducted by regulatory authorities, which all have unique regulations and caveats. These nuances make inspection readiness a difficult and resource-consuming battle. Clinical trials must be prepared for visits from countless stakeholders over their course.

In our research within the pharmaceutical industry, organizational culture should prioritize inspection readiness as a major part of clinical trial success. Unfavorable inspection findings will cause issues that could delay trials or even shut down drug development. Concentrating on more areas of inspection readiness — such as metrics, data integrity, and technology — can guarantee these findings are never a surprise.

At the 8th Clinical Trials Inspection Readiness Summit, you will understand the importance of an organizational culture of inspection readiness and how to implement that cultural change. With two days of advanced sessions, roundtables, and case studies about effective documentation standards, the culture of preparedness and improved stakeholder engagement, you will shift your organization to a quality-first, quality-always culture.

Learn more »

Connect With Us

Blog Facebook LinkedIn Twitter